Takeda, K., Kaisho, T. & Akira, S. Toll-like receptors. Annu. Rev. Immunol. 21, 335–376 (2003).
Beutler, B. & Rietschel, E.T. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3, 169–176 (2003).
Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499–511 (2004).
Ulevitch, R.J. Therapeutics targeting the innate immune system. Nat. Rev. Immunol. 4, 512–520 (2004).
Lotze, M.T. & Tracey, K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5, 331–342 (2005).
Srivastava, P. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2, 185–194 (2002).
Tsan, M.F. & Gao, B. Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76, 514–519 (2004).
Lolis, E. & Bucala, R. Therapeutic approaches to innate immunity: severe sepsis and septic shock. Nat. Rev. Drug Discov. 2, 635–645 (2003).
Angus, D.C. et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303–1310 (2001).
Foell, D. & Roth, J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum. 50, 3762–3771 (2004).
Roth, J. et al. MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood 82, 1875–1883 (1993).
Roth, J., Vogl, T., Sorg, C. & Sunderkotter, C. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol. 24, 155–158 (2003).
Odink, K. et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330, 80–82 (1987).
Vogl, T., Roth, J., Sorg, C., Hillenkamp, F. & Strupat, K. Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 detected by ultraviolet matrix-assisted laser desorption/ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 10, 1124–1130 (1999).
Vogl, T. et al. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 104, 4260–4268 (2004).
Manitz, M.P. et al. Loss of S100A9 (MRP14) results in a reduced IL-8 induced CD11b surface expression, a polarized microfilament system and a diminished responsiveness upon chemoattractants in vitro. Mol. Cell. Biol. 23, 1034–1043 (2003).
Hobbs, J.A. et al. Myeloid cell function in MRP-14 (S100A9) null mice. Mol. Cell. Biol. 23, 2564–2576 (2003).
Frosch, M. et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 43, 628–637 (2000).
Rammes, A. et al. Myeloid related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J. Biol. Chem. 272, 9496–9502 (1997).
Viemann, D. et al. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 105, 2955–2962 (2005).
Ehrhardt, C. et al. Polyethylenimine, a cost-effective transfection reagent. Signal Transduct. 6, 179–184 (2006).
Ludwig, S. et al. Influenza virus-induced AP-1–dependent gene expression requires activation of the JNK signaling pathway. J. Biol. Chem. 276, 10990–10998 (2001).
Galanos, C., Freudenberg, M.A. & Reutter, W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 76, 5939–5943 (1979).
Sampson, B. et al. Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism. Lancet 360, 1742–1745 (2002).
Haziot, A. et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 4, 407–414 (1996).
Jack, R.S. et al. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 389, 742–745 (1997).
Wurfel, M.M. et al. Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J. Exp. Med. 186, 2051–2056 (1997).
Marino, M.W. et al. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94, 8093–8098 (1997).
Kotlyarov, A. et al. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. 1, 94–97 (1999).
Shimazu, R. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777–1782 (1999).
Passey, R.J. et al. A null mutation in the inflammation-associated S100 protein S100A8 causes early resorption of the mouse embryo. J. Immunol. 163, 2209–2216 (1999).
Corr, M. The tolls of arthritis. Arthritis Rheum. 52, 2233–2236 (2005).
Hofmann, M.A. et al. RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides. Cell 97, 889–901 (1999).
Fuellen, G., Foell, D., Nacken, W., Sorg, C. & Kerkhoff, C. Absence of S100A12 in mouse: implications for RAGE-S100A12 interaction. Trends Immunol. 24, 622–624 (2003).
Clark, M.A. et al. Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis–a randomized, clinical trial. Crit. Care Med. 26, 1650–1659 (1998).
Fisher, C.J. Jr. et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N. Engl. J. Med. 334, 1697–1702 (1996).
Vandal, K. et al. Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J. Immunol. 171, 2602–2609 (2003).
Brandl, K., Gluck, T., Hartmann, P., Salzberger, B. & Falk, W. A designed TLR4/MD-2 complex to capture LPS. J. Endotoxin Res. 11, 197–206 (2005).
Qureshi, S.T. et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189, 615–625 (1999).
Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085–2088 (1998).
Hunter, M.J. & Chazin, W.J. High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14. J. Biol. Chem. 273, 12427–12435 (1998).
Viemann, D. et al. Transcriptional profiling of IKK2/NF-kappa B- and p38 MAP kinase-dependent gene expression in TNF-alpha–stimulated primary human endothelial cells. Blood 103, 3365–3373 (2004).
Tenbrock, K., Juang, Y.T., Tolnay, M. & Tsokos, G.C. The cyclic adenosine 5′-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism. J. Immunol. 170, 2971–2976 (2003).
Bosisio, D. et al. Stimulation of Toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 99, 3427–3431 (2002).
Ahmad-Nejad, P. et al. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32, 1958–1968 (2002).
Nacken, W., Sopalla, C., Propper, C., Sorg, C. & Kerkhoff, C. Biochemical characterization of the murine S100A9 (MRP14) protein suggests that it is functionally equivalent to its human counterpart despite its low degree of sequence homology. Eur. J. Biochem. 267, 560–565 (2000).